Tag Archive for ‘pancreatic cancer’

ACS CRP

Modified FOLFIRINOX is superior to gemcitabine as adjuvant therapy for resected pancreatic cancer: The PRODIGE 24/CCTG PA6 Trial

The study design and findings of the PRODIGE 24/CCTG PA6 Trial are outlined, which showed improved survival with modified FOLFIRINOX for resected pancreatic cancer patients.

JACS

Coming next month in JACS, and online now: Distal cholangiocarcinoma and pancreas cancer

This news brief highlights a JACS article that examines the results of a distal cholangiocarcinoma and pancreatic cancer multi-institution study.

Figure 1. Schema for SWOG Trial 1505

Two studies pave the way for preoperative therapy in pancreatic cancer patients

Pancreatic cancer is the fourth-most common cause of cancer-related death in the U.S. and is predicted to soon be the third-leading cause. Surgical resection with pancreatectomy has historically been viewed as offering the only chance for cure. However, achieving negative margins at surgery can be difficult, with positive surgical margins found in as many as […]

figure 1

Improving resection rates in borderline resectable pancreatic cancer: Pilot study shows favorable results

The clinical importance of the Alliance A021101 cooperative group study as well as the design of the trial itself are the focus of this month’s column.

Borderline resectable pancreatic cancer: Pushing the technical limits of surgery

This column discusses how multimodality therapy, including surgical resection, now represents a potential route to long-term survival for a group of patients with so-called “borderline resectable” cancers.

Contact

Bulletin of the American College of Surgeons
633 N. Saint Clair St.
Chicago, IL 60611

Archives

Download the Bulletin App

Apple Store
Get it on Google Play
Amazon store